PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Sukino Healthcare offers post-COVID-19 multidisciplinary rehabilitative treatment

The treatment is an amalgamation of physio, occupational and respiratory therapy

Sukino Healthcare, India’s first and only continuum care provider, has announced the launch of its post-COVID-19 multidisciplinary respiratory distress rehabilitative treatment for patients who have recovered yet suffer from the after effects of COVID-19.

Bengaluru based Sukino Healthcare’s round the clock team of doctors, nurses and caregivers with their unique and multidimensional patient centric approach have helped patients make remarkable progress within just a month of the rehabilitative care.

Often, COVID-19 patients need a level of medical care and rehabilitation that is difficult to achieve at home. Some of them need continuous monitoring and non-invasive clinical intervention supervised by a medical expert. Once the patient is admitted, a detailed assessment in carried out by Sukino Healthcare’s Physio, Occupational and Respiratory therapists for mapping out the therapy sessions and fine-tuning a goal oriented treatment plan depending on the condition of the patient.

Over the course of the treatment, the progress of the patient is assessed on a weekly basis with the Borg Dyspnea Scale, six minutes walk test, 12 minutes walk test, TUG scale and the Cough Sputum Score. The treatment is an amalgamation of physio, occupational and respiratory therapy.

Rajinish Menon, Founder and CEO, Sukino Healthcare said, “Optimal care is crucial for speedy recovery and early return to normal life at home after discharge from the hospital. We at Sukino act as the bridge between the hospital and the home, delivering out-of-hospital care that enables the patients to achieve optimal recovery in a best suited environment.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026